Advancement in forensics is escalating the Asia-Pacific Biotechnology Market

Published: Sep 2020

Asia-Pacific biotechnology market is projected to grow at a significant CAGR of 7.1% during the forecast period (2020-2026). Rising crime cases and the adoption of forensics for solving the cases is considered one of the major factors which are augmenting the adoption of biotechnology in the region. Along with this, the technical advancement in the forensics tool is expected to provide future growth opportunities to the market. In addition, various government initiatives support the biotechnology market. In order to fasten and ensure speedy justice in criminal cases, there is an increased demand for the development and adoption of modern technologies in forensic science. 

Browse the full report description Asia-Pacific Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/request-sample/asia-pacific-biotechnology-market 

For instance, in August 2018, the Indian government asked forensic experts to adopt modern techniques for DNA profiling, and also the DNA Technology Regulation Bill 2018 was approved by the Indian government in order to encourage the forensic testing. The Malaysian government is also looking forward to the adoption of advanced systems for solving crime cases. in October 2019, the Malaysian government stated that more than 60 cases were solved using Forensic DNA Databank, by various DNA profiling. Thus, the increased adoption, as well as the need for advanced technologies, is expected to provide ample opportunities to the market during the forecast period.

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Type

Countries Covered

China, India, Japan, and Rest of Asia-Pacific

Key Companies Profiled

Amgen Inc., Novo Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck & Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc.

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment/region dominates the market in the base year?
  • Which segment/region will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID 

o Most affected region/segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Asia-Pacific Biotechnology Market – Segmentation

By Type

  • Healthcare
  • Crop Production and Agriculture
  • Industrial 
  • Natural Resources & Environment
  • Others (Bioinformatics) 

Asia-Pacific Biotechnology Market – Segmentation by Geography

  • China
  • India
  • Japan
  • Rest of Asia-Pacific

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-biotechnology-market